Research
Energy balance
The evidence supporting GLP-1RAs for treating PsO and PsA remains limited.
Further clinical research is needed to establish the efficacy and safety of GLP-1RAs for PsO and PsA.
StrongQualifiesmedium confidence
Although promising, the evidence supporting GLP-1RAs for treating PsO and PsA remains limited.
Why this rating
The claim is based on the authors' assessment of the current research landscape.
Source
What Clinicians Need to Know About Glucagon-like Peptide 1 Agonists
Dimitri Luz Felipe da Silva et al. · The Journal of Rheumatology · 2025
DOI 10.3899/jrheum.2025-0531
reviewCited 2×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →